Xu Li: Clinical Trials

1 trial sponsored by Xu Li, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Xu Li: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy
Nafamostat mesilate, 5% glucose - Sepsis, Sepsis-induced Coagulopathy
Phase 4UnknownXu Li7782023-10-012023-10-12

Conditions studied

Sepsis (1)

Interventions

Glucose (1)  ·  nafamostat (1)

Results publications

PMID 40731293